Ticker Details
Caribou Biosciences, Inc.
IPO Date:	July 23, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$177.96M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.23%
Avg Daily Range (30 D):	$0.04 | 2.63%
Avg Daily Range (90 D):	$0.06 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	1.19M
Avg Daily Volume (30 D):	1.17M
Avg Daily Volume (90 D):	1.54M

Trade Size
Avg Trade Size (Sh.):	148
Avg Trade Size (Sh.) (30 D):	189
Avg Trade Size (Sh.) (90 D):	196

Institutional Trades
Total Institutional Trades:	525
Avg Institutional Trade:	$1.76M
Avg Institutional Trade (30 D):	$1.52M
Avg Institutional Trade (90 D):	$1.86M
Avg Institutional Trade Volume:	.3M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.91M
Avg Closing Trade (30 D):	$15.69M
Avg Closing Trade (90 D):	$5.63M
Avg Closing Volume:	333.75K

News

Jun 29, 2026 @ 12:00 PM Caribou Biosciences to Participate in the H.C. Wai... Source: Na

Jun 11, 2026 @ 12:00 PM Caribou Biosciences Reports Dose Escalation Durabi... Source: Na

Jan 22, 2026 @ 9:56 AM Genome Editing Market Forecast to Reach $23.6 Bill... Source: Researchandmarkets.Com

Nov 3, 2025 @ 12:00 PM Caribou Biosciences Announces Positive Data from C... Source: Caribou Biosciences

Oct 2, 2025 @ 5:00 PM CRISPR Therapies Clinical Trial Pipeline Shows Pot... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.08	$-.24	$-.26
Diluted EPS	$-1.08	$-.24	$-.26
Revenue	$10.04M	$1.5M	$2.4M
Gross Profit
Net Income / Loss	$-103.4M	$-24.28M	$-25.09M
Operating Income / Loss	$-109.47M	$-25.34M	$-26.28M
Cost of Revenue
Net Cash Flow	$.95M	$14.09M	$-.3M
PE Ratio